ABCL AbCellera Biologics

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

VANCOUVER, British Columbia--(BUSINESS WIRE)--

(Nasdaq: ABCL) will announce its third quarter 2024 financial results on Monday, November 4, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

A live audio webcast of the earnings conference may be accessed through a link that will be posted on . A replay will be available through the same link following the conference call.

About AbCellera Biologics Inc.

(Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit .

EN
26/09/2024

Underlying

ABCLAbCellera Biologics

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AbCellera Biologics

 PRESS RELEASE
Free
ABCL AbCellera Biolo...

AbCellera to Present at Upcoming Investor Conferences in December and ...

VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences: Piper Sandler 36th Annual Healthcare Conference in New York, NY on Tuesday, December 3, 2024, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time) 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025, at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time) Live audio webcasts of the presentation may be accessed through the link that will be posted on . Replays of the webcast will be av...

November 21, 2024 1 EN
 PRESS RELEASE
Free
ABCL AbCellera Biolo...

AbCellera Presents Data on Applications of T-Cell Engager Platform at ...

VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) platform, to be presented as a poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting at the George R. Brown Convention Center in Houston, Texas. AbCellera’s presentation, which is available for viewing , describes: Strategies to address key challenges in TCE development: CD3-binding antibodies to widen the therapeutic window by generating TCEs with potent tumor-cell killing and optimal cytokine release Molecules to enhance efficacy for solid tumor ind...

November 7, 2024 1 EN
 PRESS RELEASE
Free
ABCL AbCellera Biolo...

AbCellera Reports Q3 2024 Business Results

VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced financial results for the third quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “Through the third quarter we continued to execute on our key priorities of advancing our internal pipeline and building capabilities to support clinical trials activities in 2025 and beyond,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “Notably, we completed the consolidation into our new headquarters in Vancouver, Canada, which marks a significant mil...

November 4, 2024 1 EN
 PRESS RELEASE
Free
ABCL AbCellera Biolo...

AbCellera to Present at Upcoming Investor Conferences in November 2024

VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced that executives from the Company will be presenting at the following investor conferences: Stifel Healthcare Conference on Monday, November 18, 2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 10:00 a.m. Pacific Time (5:00 p.m. Greenwich Mean Time) Live audio webcasts of each presentation may be accessed through links that will be posted on . Replays of each webcast will be available through the same links following the presentat...

October 22, 2024 1 EN
 PRESS RELEASE
Free
ABCL AbCellera Biolo...

AbCellera Announces Presentation on T-cell Engager Platform at the Soc...

VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced an upcoming poster presentation on its T-cell engager platform at the SITC 39th Annual Meeting, to be held November 6 to 10 at the George R. Brown Convention Center in Houston, Texas. Details on AbCellera’s poster presentation at SITC are as follows: Title: Profiling bispecific T-cell engagers: Strategies for enhancing potency while minimizing cytokine release Abstract Number: 1291 Date and Time: Friday, November 8 from 9:00 a.m. to 7:00 p.m. CST Location: Exhibit Halls A B George R. Brown Convention Center or onl...

October 4, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch